Stengone Carmine N. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$4,600.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Stengone Carmine N.

According to the SEC Form 4 filings, Stengone Carmine N., being in a position of

  1. CEO and President at Contineum Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 25000 shares for $401,378,
    over all time since 2026-02-11, has bought 0 shares, and sold 25000 shares for $401,378.

Biography of Stengone Carmine N.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $401,3787100

Comparison of Insiders on Amount of Buys and Sells

2026-09-08SaleContineum Therapeutics, Inc.
CTNM
CEO and President
2,500
0.0069%
$16.46$41,142-21.36%
2026-08-03SaleContineum Therapeutics, Inc.
CTNM
CEO and President
2,500
0.0067%
$16.01$40,029-15.07%
2026-07-08SaleContineum Therapeutics, Inc.
CTNM
CEO and President
2,500
0.0073%
$16.00$40,000-9.52%
2026-06-30SaleContineum Therapeutics, Inc.
CTNM
CEO and President
10,000
0.0261%
$16.01$160,080-12.75%
2026-02-25SaleContineum Therapeutics, Inc. Class A Common Stock
CTNM
CEO and President
2,700
0.0075%
$16.02$43,242-14.8%
2026-02-24SaleContineum Therapeutics, Inc. Class A Common Stock
CTNM
CEO and President
4,400
0.0121%
$16.02$70,486-15.57%
2026-02-11SaleContineum Therapeutics, Inc. Class A Common Stock
CTNM
CEO and President
400
0.0011%
$16.00$6,400-11.34%
2024-09-11PurchaseKiora Pharmaceuticals, Inc.
KPRX
director
1,250
0.0442%
$3.68$4,600-9.22%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.